• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于吩噻嗪的诊疗化合物的开发,该化合物既作为β-淀粉样蛋白聚集的抑制剂,又作为阿尔茨海默病中淀粉样斑块的成像探针。

Development of Phenothiazine-Based Theranostic Compounds That Act Both as Inhibitors of β-Amyloid Aggregation and as Imaging Probes for Amyloid Plaques in Alzheimer's Disease.

作者信息

Dao Pascal, Ye Feifei, Liu Yan, Du Zhi Yun, Zhang Kun, Dong Chang Zhi, Meunier Bernard, Chen Huixiong

机构信息

Faculty of Light Industry and Chemical Engineering, Guang Dong University of Technology , Guangzhou, Guang Dong 510006, China.

Université Paris Diderot, Sorbonne Paris Cité , ITODYS, UMR 7086 CNRS, 15 rue J-A de Baïf, 75205 Cedex 13 Paris, France.

出版信息

ACS Chem Neurosci. 2017 Apr 19;8(4):798-806. doi: 10.1021/acschemneuro.6b00380. Epub 2017 Feb 2.

DOI:10.1021/acschemneuro.6b00380
PMID:28097868
Abstract

Early detection of Alzheimer's disease (AD) is imperative in enabling the understanding and clinical treatment of this disorder, as well as in preventing its progression. Imaging agents specifically targeting Aβ plaques in the brain and the retina may lead to the early diagnosis of AD. Among them, near-infrared fluorescent (NIRF) imaging has emerged as an attractive tool to noninvasively identify and monitor diseases during the preclinical and early stages. In the present study, we report the design, synthesis, and evaluation of a series of new near-infrared fluorescent probes. Most of these probes displayed maximum emission in PBS (>650 nm), which falls in the good range for NIRF probes. Among them, 4a1 showed the highest affinity toward Aβ aggregates (K = 7.5 nM) and an excellent targeting ability for Aβ plaques in slices of brain and retina tissue from double transgenic mice. These compounds are also found to effectively prevent Aβ fibril formation and disaggregate preformed Aβ fibrils, showing a promising potential as theranostic agents for the diagnosis and therapy of AD.

摘要

阿尔茨海默病(AD)的早期检测对于理解和临床治疗这种疾病以及预防其进展至关重要。专门针对大脑和视网膜中Aβ斑块的成像剂可能有助于AD的早期诊断。其中,近红外荧光(NIRF)成像已成为一种有吸引力的工具,可在临床前和早期阶段非侵入性地识别和监测疾病。在本研究中,我们报告了一系列新型近红外荧光探针的设计、合成和评估。这些探针中的大多数在PBS中显示出最大发射波长(>650 nm),这对于NIRF探针来说处于良好范围。其中,4a1对Aβ聚集体表现出最高亲和力(K = 7.5 nM),并且对双转基因小鼠脑和视网膜组织切片中的Aβ斑块具有出色的靶向能力。这些化合物还被发现能有效防止Aβ纤维形成并使预先形成的Aβ纤维解聚,显示出作为AD诊断和治疗的诊疗试剂的潜在前景。

相似文献

1
Development of Phenothiazine-Based Theranostic Compounds That Act Both as Inhibitors of β-Amyloid Aggregation and as Imaging Probes for Amyloid Plaques in Alzheimer's Disease.基于吩噻嗪的诊疗化合物的开发,该化合物既作为β-淀粉样蛋白聚集的抑制剂,又作为阿尔茨海默病中淀粉样斑块的成像探针。
ACS Chem Neurosci. 2017 Apr 19;8(4):798-806. doi: 10.1021/acschemneuro.6b00380. Epub 2017 Feb 2.
2
Smart near-infrared fluorescence probes with donor-acceptor structure for in vivo detection of β-amyloid deposits.具有给体-受体结构的智能近红外荧光探针,用于体内检测β-淀粉样蛋白沉积。
J Am Chem Soc. 2014 Mar 5;136(9):3388-94. doi: 10.1021/ja4052922. Epub 2014 Feb 20.
3
Development of novel theranostic agents for in vivo amyloid imaging and protective effects on human neuroblastoma cells.新型治疗诊断试剂的研发用于活体淀粉样蛋白成像及对人神经母细胞瘤细胞的保护作用。
Eur J Med Chem. 2019 Nov 1;181:111585. doi: 10.1016/j.ejmech.2019.111585. Epub 2019 Aug 3.
4
Discovery of boronic acid-based fluorescent probes targeting amyloid-beta plaques in Alzheimer's disease.靶向阿尔茨海默病中淀粉样β斑块的硼酸基荧光探针的发现。
Bioorg Med Chem Lett. 2016 Apr 1;26(7):1784-8. doi: 10.1016/j.bmcl.2016.02.042. Epub 2016 Feb 16.
5
Engineering of donor-acceptor-donor curcumin analogues as near-infrared fluorescent probes for imaging of amyloid-β species.设计供体-受体-供体姜黄素类似物作为近红外荧光探针用于淀粉样β物种的成像。
Theranostics. 2022 Apr 4;12(7):3178-3195. doi: 10.7150/thno.68679. eCollection 2022.
6
Rational design synthesis and evaluation of a novel near-infrared fluorescent probe for selective imaging of amyloid-β aggregates in Alzheimer's disease.新型近红外荧光探针用于阿尔茨海默病中淀粉样β聚集物的选择性成像的合理设计合成与评价。
Anal Chim Acta. 2023 Nov 15;1281:341900. doi: 10.1016/j.aca.2023.341900. Epub 2023 Oct 10.
7
Development of fluorescent probes that bind and stain amyloid plaques in Alzheimer's disease.用于结合和染色阿尔茨海默病中淀粉样斑块的荧光探针的开发。
Arch Pharm Res. 2015 Nov;38(11):1992-8. doi: 10.1007/s12272-015-0617-4. Epub 2015 May 27.
8
Near-infrared Fluorescence Ocular Imaging (NIRFOI) of Alzheimer's Disease.阿尔茨海默病的近红外荧光眼部成像(NIRFOI)。
Mol Imaging Biol. 2019 Feb;21(1):35-43. doi: 10.1007/s11307-018-1213-z.
9
Synthesis and evaluation of curcumin-based near-infrared fluorescent probes for the in vivo optical imaging of amyloid-β plaques.基于姜黄素的近红外荧光探针的合成与评价及其用于淀粉样β斑块的体内光学成像。
Bioorg Chem. 2021 Oct;115:105167. doi: 10.1016/j.bioorg.2021.105167. Epub 2021 Jul 16.
10
A Novel Near-Infrared Fluorescence Probe THK-565 Enables In Vivo Detection of Amyloid Deposits in Alzheimer's Disease Mouse Model.一种新型近红外荧光探针 THK-565 可用于活体检测阿尔茨海默病小鼠模型中的淀粉样沉积。
Mol Imaging Biol. 2023 Dec;25(6):1115-1124. doi: 10.1007/s11307-023-01843-4. Epub 2023 Aug 14.

引用本文的文献

1
Fluphenazine, an antipsychotic compound, ameliorates Alzheimer's disease by clearing amyloid beta accumulation in C. elegans.氟奋乃静是一种抗精神病化合物,它通过清除秀丽隐杆线虫中的β-淀粉样蛋白积累来改善阿尔茨海默病。
Geroscience. 2025 Sep 9. doi: 10.1007/s11357-025-01861-w.
2
Ligands for Protein Fibrils of Amyloid-β, α-Synuclein, and Tau.淀粉样β蛋白、α-突触核蛋白和tau蛋白原纤维的配体
Chem Rev. 2025 Jun 11;125(11):5282-5348. doi: 10.1021/acs.chemrev.4c00838. Epub 2025 May 6.
3
Photoredox Catalysts Based on N-(Hexyl)benzothioxanthene-3,4-dicarboximide for Photopolymerization and 3D Printing Under Visible Light.
基于N-(己基)苯并噻吨-3,4-二甲酰亚胺的光氧化还原催化剂用于可见光下的光聚合和3D打印
Angew Chem Int Ed Engl. 2025 Jul 21;64(30):e202501442. doi: 10.1002/anie.202501442. Epub 2025 Apr 25.
4
Bromothiolation of Arynes for the Synthesis of 2-Bromobenzenethiol Equivalents.用于合成2-溴苯硫醇等效物的芳炔的溴硫醇化反应
Org Lett. 2024 May 10;26(18):3816-3821. doi: 10.1021/acs.orglett.4c00944. Epub 2024 Apr 30.
5
Recent Advances in Fluorescent Theranostics for Alzheimer's Disease: A Comprehensive Survey on Design, Synthesis, and Properties.阿尔茨海默病荧光诊疗学的最新进展:关于设计、合成及性质的全面综述
ACS Omega. 2024 Mar 11;9(12):13556-13591. doi: 10.1021/acsomega.3c10417. eCollection 2024 Mar 26.
6
Recent progress of small-molecule-based theranostic agents in Alzheimer's disease.基于小分子的阿尔茨海默病诊疗试剂的最新进展
RSC Med Chem. 2023 Sep 14;14(11):2231-2245. doi: 10.1039/d3md00330b. eCollection 2023 Nov 15.
7
Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.多功能纳米载体治疗阿尔茨海默病:突破障碍。
Mol Neurobiol. 2024 May;61(5):3042-3089. doi: 10.1007/s12035-023-03730-z. Epub 2023 Nov 15.
8
Small molecules and conjugates as theranostic agents.作为治疗诊断剂的小分子与偶联物。
RSC Chem Biol. 2023 Sep 2;4(11):826-849. doi: 10.1039/d3cb00073g. eCollection 2023 Nov 1.
9
Two-Photon Fluorescent Probes for Amyloid-β Plaques Imaging In Vivo.用于体内淀粉样斑块成像的双光子荧光探针。
Molecules. 2023 Aug 22;28(17):6184. doi: 10.3390/molecules28176184.
10
Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks.阿尔茨海默病的当前及未来治疗策略:药物研发瓶颈概述
Front Aging Neurosci. 2023 Aug 3;15:1206572. doi: 10.3389/fnagi.2023.1206572. eCollection 2023.